IP Library Granted Patent US 10,295,549
Granted Patent B2
US 10,295,549 · App. 15/254,146 · Granted May 21, 2019

Diagnostic devices and methods of use

Inventor: Jonathan E. Valla (Phoenix, AZ)
Assignee: DIGNITY HEALTH
G01N33/6896B01L3/5021B01L3/50273B01L3/502715B01L3/502761B01L3/502753B01L2200/0647B01L2300/0609B01L2300/069B01L2300/0681B01L2300/0822B01L2300/0838B01L2300/0887B01L2400/0406B01L2400/0409G01N2333/90216G01N2800/28G01N2800/2814G01N2800/2821
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,295,549
App. No.
15/254,146
Granted
May 21, 2019
Kind
B2
Abstract

The present invention relates to methods of diagnosing samples as well as various microfluidic, microcentrifuge and microfilter devices. In one embodiment, the present invention provides a method of diagnosing neurodegenerative diseases using mitochondrial and/or platelet samples. In another embodiment, the present invention provides a microfluidic device that selectively captures and analyzes a desired amount of target biological particle.

Claims (12)

1. A method of processing a liquid sample from a subject, the method comprising the steps of:

obtaining a liquid sample from the subject;

adding a reagent to the liquid sample;

centrifuging the liquid sample to obtain platelet-rich plasma (PRP) fraction comprising unlysed platelets;

combining the PRP fraction with a staining solution;

concentrating the stained PRP fraction comprising unlysed platelets within a device comprising an optical measurement chamber; and

quantifying an amount or activity of a mitochondrial protein within the concentrated PRP fraction comprising unlysed platelets from the subject.

2. The method of claim 1 , wherein the reagent comprises an anticoagulant.

3. The method of claim 2 , wherein the anticoagulant comprises acid citrate dextrose.

4. The method of claim 1 , wherein concentrating the stained PRP fraction comprises centrifuging the stained PRP fraction within the device.

5. The method of claim 1 , wherein the mitochondrial protein comprises a mitochondrial electron transport chain enzyme.

6. The method of claim 5 , wherein the mitochondrial electron transport chain enzyme comprises cytochrome oxidase.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2016
From: VALLA, JONATHAN E.
To: CATHOLIC HEALTHCARE WEST
Reel/Frame 040517/0993 →
CHANGE OF NAME Recorded Dec 5, 2016
From: CATHOLIC HEALTHCARE WEST
To: DIGNITY HEALTH
Reel/Frame 040815/0218 →
Continuity (4)
Continuation 13203333
Provisional Application 61156717 · Mar 2, 2009
Provisional Application 61156734 · Mar 2, 2009
Related Publication 20170089925A1 · Mar 30, 2017